---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-079590"
form_type: "8-K"
ticker: "RGNX"
cik: "0001590877"
company_name: "REGENXBIO Inc."
filed_at: "2022-03-18T23:59:59+00:00"
generated_at: "2026-06-26T21:41:40.534856+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# REGENXBIO director Daniel Abdun-Nabi will not stand for re-election at 2022 annual meeting

## Summary
- Daniel J. Abdun-Nabi informed REGENXBIO he will not stand for re-election at the 2022 annual meeting.
- His term expires at the 2022 annual meeting; decision not due to any disagreement with the company.
- He served nearly six years as a director; company thanked him for his service.

## SEC filing metadata
- accession: 0001193125-22-079590
- form_type: 8-K
- ticker: RGNX
- cik: 0001590877
- company_name: REGENXBIO Inc.
- filed_at: 2022-03-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1590877/000119312522079590/0001193125-22-079590-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1590877/000119312522079590/d318267d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-079590
- JSON: https://secwatch.observer/filing/0001193125-22-079590.json
- Plain text: https://secwatch.observer/filing/0001193125-22-079590.txt

## Key facts
- Executive change
  Daniel J. Abdun-Nabi departed as Director at REGENXBIO Inc..
  - Action: will not stand for re-election
  - Role: Director
  source text: On March 14, 2022, Daniel J. Abdun-Nabi notified REGENXBIO Inc. (the “Company”) that he will not stand for re-election as a director of the Company at the end of his current term, which expires at the Company’s 2022 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1590877/000119312522079590/0001193125-22-079590-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.